What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2024-05-07 compared with 2023-11-15 · 52 added, 382 removed, 1 unchanged (100% of the section changed)

as described below, there have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K

filed with the SEC on March 22, 2023.

The disclosure of risks identified below does not imply that the risk has not already

materialized.

may need additional capital to execute our business plan and fund operations and may not be able to obtain such capital on acceptable

terms or at all.

expect to incur significant ongoing operating expenses in connection with the execution of our business strategies.

We also expect to

incur significant capital expenses as we seek to expand our business.

Our efforts to obtain needed capital resources and sources of liquidity

may not be sufficient to support our business operations and future growth strategies.

If we are unable to satisfy our liquidity and capital

resource requirements, we may have to scale back, postpone or discontinue our growth strategies, which could result in slower growth or

no growth, and we may lose key suppliers, be unable to timely satisfy customer orders, and be unable to retain our employees.

we may be forced to restructure our obligations to creditors, pursue work-out options or other protective measures.

Our ability to access funds under the ABL Agreement (the “ABL

Loans”) is subject to certain conditions, availability reserves, minimum availability requirements, borrowing base calculations

and restrictive covenants, and there is no guarantee that we will be able to satisfy such conditions and restrictive covenants.

because the amount available under the ABL Agreement is based on our borrowing base calculations and minimum availability requirements

at the time of any draw, the amount available to us will change from time to time.

In October 2023, the ABL Lenders implemented an availability

reserve of $5.0 million, which reduces the amount available under our borrowing base.

Certain events of default

occurred under each of the 2023 Credit Agreements due to (i) the Company’s failure to (a) provide certain financial reporting and

related materials on a timely basis and (b) complete certain post-closing deliverables as required under the ABL Agreement and (ii) the

Company drawing on the loan under the ABL Agreement while the above events of default were in existence.

In addition, the ABL Amendment

and Term Loan Amendment increased our reporting obligations under the 2023 Credit Agreements and if we are not able to maintain compliance

with such additional requirements we may experience future events of default, which could limit our ability to access the ABL Loans and

adversely affect our financial position and operations.

the extent that waivers and amendments are necessary under either of the 2023 Credit Agreements, there can be no guarantee that we will

be able to obtain waivers or amendments from the applicable Lenders if, in the future, we are unable to comply with the covenants and

other terms of the 2023 Credit Agreements.

Our failure to satisfy the required conditions under the 2023 Credit Agreements or maintain

compliance with the financial and performance covenants under the 2023 Credit Agreements could result in future defaults, which would

adversely affect our financial condition and results of operations, including, potentially, as a result of acceleration of our outstanding

We would also be restricted from drawing on the ABL Loans while an event of default is continuing.

In addition, any default under

the 2023 Credit Agreements would adversely affect our ability to obtain alternative financing, including additional indebtedness from

subordinated lenders.

our ability to obtain additional capital on acceptable terms or at all is subject to a variety of uncertainties.

Adequate alternative

financing may not be available or, if available, may only be available on unfavorable terms or subject to covenants that we may not be

able to satisfy.

is no assurance we will obtain the capital we require.

As a result, there can be no assurance that we will be able to fund our future

operations or growth strategies.

equity or debt financings may require us to also issue warrants or other equity securities that are likely to be dilutive to our existing

stockholders.

For example, on February 13, 2023, we completed an offering of our Class A Shares that increased the number of outstanding

Class A Shares from 91,380,323 to 104,780,323.

Newly issued securities may include preferences or superior voting rights or may be combined

with the issuance of warrants or other derivative securities, which each may have additional dilutive effects.

Furthermore, we may incur

substantial costs in pursuing future capital and financing, including investment banking fees, legal fees, accounting fees, printing

and distribution expenses and other costs.

We may also be required to recognize non-cash expenses in connection with certain

securities we may issue, such as convertible notes and warrants, which will adversely impact our financial condition.

If we cannot raise

additional funds on favorable terms or at all, we may not be able to carry out all or parts of our long-term growth strategy, maintain

our growth and competitiveness or continue in business.

Our level of indebtedness

and related covenants could limit our operational and financial flexibility and adversely affect our business if we breach such covenants

and default on such indebtedness.

Under the 2023 Credit Agreements,

we are subject to a number of affirmative and negative covenants, including covenants regarding dispositions of property, investments,

forming or acquiring subsidiaries, business combinations or acquisitions, incurrence of additional indebtedness, and transactions with

affiliates, among other customary covenants, in each case, subject to certain exceptions.

In particular, we are (i) restricted

from incurring additional debt up to certain amounts, subject to limited exceptions, as set forth in each 2023 Credit Agreement, and

(ii) required to maintain minimum revolving availability under the ABL Agreement, and, if revolving availability falls beneath a

specified amount, a specified Consolidated Fixed Charge Coverage Ratio (as such term is defined in the ABL Agreement).

The Loan Parties

are also restricted from paying dividends or making other distributions or payments on their capital stock, subject to limited exceptions.

These restrictions may prevent

us from taking actions that we believe would be in the best interests of the business and may make it difficult for us to successfully

execute our business strategy or effectively compete with companies that are not similarly restricted.

If we determine that we need to

take any action that is restricted under any 2023 Credit Agreement, we will need to first obtain a waiver from the applicable Agent and

Obtaining such waivers, if needed, may impose additional costs on us or we may be unable to obtain such waivers.

to comply with these restrictive covenants in future periods will largely depend on our ability to successfully implement our overall

business strategy.

The breach of any of these covenants or restrictions could result in a default, which could potentially result in the

acceleration of our outstanding debt.

In the event of an acceleration of such debt, we could be forced to apply all available cash flows

to repay such debt, which could also force us into bankruptcy or liquidation.

Certain events of default

occurred under each of the 2023 Credit Agreements due to (i) the Company’s failure to (a) provide certain financial reporting and

related materials on a timely basis and (b) complete certain post-closing deliverables as required under the ABL Agreement and (ii) the

Company drawing on the loan under the ABL Agreement while the above events of default were in existence.

In addition, the ABL Amendment

and Term Loan Amendment increased our reporting obligations under the 2023 Credit Agreements.

If we are not able to maintain compliance

with our covenants under the 2023 Credit Agreements, we may need to seek amendments or waivers to the Term Loan Agreement and ABL Agreement

in the future, and may also need to obtain alternative sources of liquidity.

Such alternative sources of liquidity, including subordinated

date, may not be available on terms favorable to us or at all.

the extent that waivers and amendments under any 2023 Credit Agreement are necessary, there can be no guarantee that we will be able to

obtain waivers or amendments from the applicable Lenders if, in the future, we are unable to comply with the covenants and other terms

of any 2023 Credit Agreement.

Our failure to satisfy the required conditions under the 2023 Credit Agreements, any amendments thereof,

or maintain compliance with the financial and performance covenants under the 2023 Credit Agreements could result in future defaults,

which would adversely affect our financial condition and results of operations, including, potentially, as a result of acceleration of

our outstanding debt.

In addition, any default under would adversely affect our ability to obtain alternative financing, and significantly

limit our ability to execute our business strategies.

We are required

to make certain prepayments to our term and revolving loans and thereafter will not be able to benefit from that portion of the term loan

and may not be able to draw upon our revolving line of credit.

the Term Loan Agreement, as amended, we have mandatory prepayment obligations (i) upon the disposition of assets

by any loan party or subsidiary resulting in net cash proceeds in excess of $1.0 million in any calendar year, and (ii) upon the receipt

of cash in excess of $1.0 million by any loan party or subsidiary not in the ordinary course of business other than permitted under the

Term Loan Agreement.

Under the ABL Agreement, as amended, we have mandatory prepayment obligations (i) in the event of certain dispositions

which result in the realization of net cash proceeds in excess of $1.0 million in any calendar year, (ii) upon the sale or issuance by

any loan party or any of its subsidiaries of any of its equity interests other than those permitted under the ABL Agreement, (iii) upon

the receipt of net cash proceeds by any loan party or subsidiary from the incurrence or issuance of debt other than permitted by the ABL

Agreement, (iv) upon the receipt of cash in excess of $1.0 million by any loan party or subsidiary not in the ordinary course of business

other than permitted under the ABL Agreement, and (v) and for over advances if at any time the total revolving credit outstanding exceeds

the borrowing base as defined under the ABL Agreement.

In addition, the ABL Agreement imposes limitations on other forms of indebtedness,

liens, investments, and other operational actions.

Moreover, under the ABL Agreement our borrowing is limited to a borrowing base that

is periodically adjusted, and if for any reason the amount we have borrowed exceeds that borrowing base we may be required to prepay amounts

equal to such excess.

If for any reason we are required to prepay any amount owed under the Term Loan Agreement or ABL Agreement, we may

not have sufficient liquidity available to make such prepayments and we would be in default under our obligations.

In addition, any prepayment

would require us to divert liquidity and capital resources away from the operating expenses of our business, which could adversely affect

our relationships with suppliers and vendors and our ability to execute on our growth strategies, and prevent us from taking actions in

our best interest or even continue in business.

have identified a material weakness in our internal control over financial reporting and i f we fail to maintain an

effective system of internal controls, we may not be able to report our financial results accurately, may make a material misstatement

in our financial statements, may experience a financial loss, or may face litigation.

Any inability to report and file our financial results

accurately and timely could harm our business and adversely affect the value of our business.

As a public company, we are

required to establish and maintain internal controls over financial reporting and disclosure controls and procedures and to comply with

other requirements of the Sarbanes-Oxley Act and the rules promulgated by the SEC.

Even when such controls are implemented, management,

including our Chief Executive Officer and Chief Financial Officer, cannot guarantee that our internal controls and disclosure controls

and procedures will prevent all possible errors or loss.

Because of the inherent limitations in all control systems, no system of controls

can provide absolute assurance that all control issues and instances of fraud, if any, within the Company or perpetrated against us will

be prevented or have been detected.

These inherent limitations include the possibility that judgments in decision-making can be faulty

and subject to simple error or mistake.

Furthermore, controls can be circumvented by individual acts of some persons, by collusion of

two or more persons, or by management override of the controls.

The design of any system of controls is based in part upon certain assumptions

about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under

all potential future conditions.

Over time, measures of control may become inadequate because of changes in conditions, new fraudulent

schemes, or the deterioration of compliance with policies or procedures.

Because of inherent limitations in a cost-effective control system,

misstatements due to error or fraud may occur and/or may not be detected.

The accuracy of our financial

reporting depends on the effectiveness of our internal control over financial reporting.

Internal control over financial reporting can

provide only reasonable assurance with respect to the preparation and fair presentation of financial statements and may not prevent or

detect misstatements.

Failure to maintain effective internal control over financial reporting, or lapses in disclosure controls and procedures,

could undermine the ability to provide accurate disclosure (including with respect to financial information) on a timely basis, which

could cause investors to lose confidence in our disclosures (including with respect to financial information), require significant resources

to remediate the lapse or deficiency, and expose us to legal or regulatory proceedings.

In the course of preparing

our financial statements as of September 30, 2023, we identified certain errors in our accounting for warranty reserves, relating specifically

to our warranty reserves under wholesale contracts.

As part of such process, we identified a material weakness in our internal controls

over financial reporting.

Our internal controls over financial reporting did not result in the proper accounting of warranty reserves

relating to our long-term warranty obligations, which due to its cumulative impact on our consolidated financial statements as of September

30, 2023, we determined to be a material weakness.

continue to evaluate, design and work through the process of implementing controls and procedures under a remediation plan designed to

address this material weakness, but there can be no assurance that we will be able to remediate this material weakness in a timely manner

If our remediation measures are insufficient to address the material weaknesses, or if additional material weaknesses or significant

deficiencies in our internal control are discovered or occur in the future, our financial statements may contain material misstatements

and we could be required to restate our financial results, which could lead to substantial additional costs for accounting and legal fees

and stockholder litigation.

We cannot guarantee that we

will not experience additional material weaknesses in our internal controls in the future.

If additional material weaknesses or significant

deficiencies in our internal control are discovered or occur in the future, our financial statements may contain material misstatements

and we could be required to restate our financial results, which could lead to substantial additional costs for accounting and legal fees

and stockholder litigation.

Any failure to maintain such

internal control could adversely impact our ability to report our financial position and results from operations on a timely and accurate

If our financial statements are not accurate, investors may not have a complete understanding of our operations.

Likewise, if our

financial statements are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which

our common stock is listed, the SEC or other regulatory authorities.

In either case, this could result in a material adverse effect on

Except as described below, there have been no material changes from

the risk factors previously disclosed in our 2023 Annual Report on Form 10-K filed with the SEC on March 12, 2024.The disclosure of risks

identified below does not imply that the risk has not already materialized.

Future sales of our Common Stock in the

public market may depress our share price.

Sales of a substantial number

of shares of our Common Stock in the public market, or the perception that these sales might occur, could depress the market price of

our Common Stock and could impair our ability to raise capital through the sale of additional equity securities or other securities convertible

into or exchangeable for equity securities, regardless of whether there is any relationship between such sales and the performance of

our business.

Failure to timely file will cause us to be ineligible to utilize short form registration statements on Form S-3, which may

impair our ability to obtain capital in a timely fashion to execute our business strategies or issue shares to effect an acquisition.

Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a

negative effect on the trading price of our stock.

As a result of our 2022 acquisition

of Intellibed, we are in the process of integrating its systems and processes into ours, including bringing such systems and processes

into our existing framework of internal controls.

That process requires us to devote resources that might otherwise be used to grow the

If we do not successfully integrate the Intellibed processes into our internal controls, there may be material misstatements

that are not detected in a timely manner.

We may face litigation

and other risks as a result of current and previous material weaknesses in our internal control over financial reporting.

have determined that a material weakness exists related to the accounting of our warranty reserves, which resulted in an understatement

of our warranty reserves in prior periods.

In addition, we have had previous material weaknesses that have been remediated, some of which

resulted in restatements of our previously issued audited financial statements.

As a result of such restatements, material weakness, and

other matters that may in the future arise, we face potential for litigation or other disputes which may include, among others, claims

invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weaknesses

in our internal control over financial reporting and the preparation of our financial statements.

As of the date of this filing, we have

no knowledge of any such litigation or dispute.

However, we can provide no assurance that such litigation or dispute will not arise in

Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of

operations and financial condition.

Anti-takeover

provisions in our Second Amended and Restated Certificate of Incorporation, our Third Amended and Restated Bylaws as well as provisions

of Delaware law, contain anti-takeover provisions, any of which could delay or discourage a merger, tender offer, or assumption of control

of the Company not approved by our Board of Directors that some stockholders may consider favorable.

Provisions of Delaware law, our Second Amended and Restated Certificate

of Incorporation, and our Third Amended and Restated Bylaws could hamper a third party’s acquisition of us or discourage a third

party from attempting to acquire control of us.

You may not have the opportunity to participate in these transactions.

These provisions

could also limit the price that investors might be willing to pay in the future for equity interests in the Company.

These provisions

the right of our Board

to elect a director to fill a vacancy created by the expansion of our Board or the resignation, death or removal of a director in

certain circumstances, which prevents stockholders from being able to fill vacancies on our Board;

a prohibition on stockholder

action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;

a prohibition on stockholders

calling a special meeting and the requirement that a meeting of stockholders may only be called by members of our Board, which may

delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;

the requirement that changes

or amendments to certain provisions of our certificate of incorporation or bylaws must be approved by holders of at least two-thirds of

our common stock;

advance notice procedures

that stockholders must comply with in order to nominate candidates to our Board or to propose matters to be acted upon at a meeting

of stockholders, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s

own slate of directors or otherwise attempting to obtain control of us.

December 2022, we amended our bylaws to add requirements relating to stockholder nominations of directors, including a requirement that

stockholder nominees complete a written questionnaire and that stockholder nominees make themselves available for interviews by our Board

upon request.

addition, we are subject to the provisions of Section 203 of the Delaware General Corporation Law, which may prohibit certain transactions

with stockholders owning 15% or more of our outstanding voting stock or require us to obtain stockholder approval prior to engaging in

such transactions.

Coliseum collectively holds approximately 44.7% of our outstanding voting stock.

Any delay or prevention of a change

in control transaction or changes in our Board could adversely affect our ability to execute transactions that are needed to carry out

our operations and growth strategies and cause the market price of our common stock to decline.

may not be able to identify, complete or successfully integrate acquisitions, and any such acquisitions may not achieve the anticipated

financial benefits, all of which could have a negative impact on our growth, financial condition, and results of operations.

may seek to acquire businesses in the future as we encounter acquisition prospects that would complement our current product offerings,

increase the size and geographic scope of our operations, or otherwise offer strategic, growth and operating efficiency opportunities.

We cannot assure investors that we will be able to identify and acquire acceptable acquisition candidates on terms favorable to us in

the future, or that any acquisitions will achieve the anticipated strategic or financial benefits.

Even if we do identify opportunities

to acquire businesses, we may not be able to consummate such acquisitions due to a number of factors, including lacking access to sufficient

capital to fund such acquisitions.

addition, acquisitions involve numerous risks and uncertainties and may be of businesses in which we lack operational or market experience.

The financing for any of these acquisitions could dilute the interests of our stockholders, result in an increase in our indebtedness

Future acquisitions could entail numerous risks, including:

difficulties in integrating

acquired technologies, operations or products;

the difficulties of imposing

financial and operating controls on the acquired companies and their management and the potential costs of doing so;

the potential loss of key

employees, customers, suppliers or distributors from acquired businesses and disruption to our direct selling channel;

diversion of management’s

attention from our core business;

the failure to achieve

the strategic objectives of these acquisitions;

increased fixed costs;

the failure of the acquired

businesses to achieve the results we have projected in either the near or long term;

the assumption of unexpected

liabilities, including compliance and litigation risks;

adverse effects on existing

business relationships with our suppliers, sales force or consumers;

Failure to gain consumer

or wholesale market acceptance of acquired brands and products;

risks associated with entering

markets or industries in which we have limited or no prior experience, including limited expertise in running the business, developing

the technology, and selling and servicing the products.

failure to successfully complete the integration of any acquired business, or a failure to effectively identify and pursue such acquisitions,

could have a material adverse effect on our business, financial condition and operating results.

Changes in accounting standards and subjective

assumptions, estimates and judgments by management related to complex accounting matters, including matters relating to our Tax Receivable

Agreement, could significantly affect our financial results.

Generally accepted accounting

principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters

that are relevant to our business are complex and involve many subjective assumptions, estimates and judgments by our management, including

but not limited to estimates that affect our revenue recognition, accounts receivable and allowance for doubtful accounts, valuation

of inventories, cost of revenues, sales returns, warranty liabilities, the recognition and measurement of loss contingencies, warrant

liabilities, estimates of current and deferred income taxes, deferred income tax valuation allowances and amounts associated with our

Tax Receivable Agreement with our founders dated February 22, 2018 (the “Tax Receivable Agreement”).

Changes in these

rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly change

our reported or expected financial performance, and could have a material adverse effect on our business and results of operations.

example, in the third quarter of 2023, management determined that certain assumptions made relating to the valuation of our fixed assets

were no longer accurate.

As a result, we were required to record an impairment charge relating to our fixed assets.

business and our reputation could be adversely affected by the failure to protect sensitive employee, customer and consumer data, or

to comply with evolving regulations relating to our obligation to protect such data.

In the ordinary course of

our business, we collect and store certain personal information from individuals, such as our customers and suppliers, and we process

customer payment card and check information for purchases via our website.

In addition, we may share with third-parties personal information

we have collected.

Cyber-attacks designed to gain access to sensitive information by breaching security systems of large organizations

leading to unauthorized release of confidential information have occurred at a number of major U.S.

companies despite widespread recognition

of the cyber-attack threat and improved data protection methods.

Computer hackers may attempt to penetrate our computer system or the

systems of third-parties with which we have shared personal information and, if successful, misappropriate personal information, payment

card or check information or confidential Company business information.

In addition, a Company employee, contractor or other third party

with whom we do business may attempt to circumvent our security measures in order to obtain such information and may purposefully or inadvertently

cause a breach involving such information.

For example, though it did not involve access to or release of personal information, we recently

experienced an unauthorized intrusion into one of our vendor’s systems using a former contractor’s credentials that resulted

in access to email addresses and an unauthorized email being sent under a valid Purple email address.

Breaches involving any personal

information could be more likely to the extent we have any material weakness in internal control over financial reporting related to information

technology general controls in the areas of user access and segregation of duties related to certain IT systems that support the Company’s

financial reporting processes.

and third parties with which we have shared personal information have been subject to attempts to breach the security of networks, IT

infrastructure, and controls through cyber-attack, malware, computer viruses, social engineering attacks, ransomware attacks, and other

means of unauthorized access.

For example, in 2022, we experienced a spear-phishing attack that resulted in the unauthorized change to

a significant vendor’s bank account to which we made payments that were lost in part until the scheme was discovered.

that this attack will result in costs to us of up to $250,000.

We anticipate that we may, in the future, continue to be subject to these

and similar cyber threats.

A breach of systems resulting in the unauthorized release of sensitive data could also adversely affect our

reputation and lead to financial losses from remedial actions or potential liability, possibly including punitive damages, and could

also materially increase the costs we already incur to protect against these risks.

In addition, cyber-attacks, such as ransomware attacks,

if successful, could interfere with our ability to access and use systems and records that are necessary to operate our business.

attacks could materially adversely affect our reputation, relationships with customers, and operations and could require us to expend

significant resources to resolve such issues.

We continue to balance the additional risk with the cost to protect us against a breach.

Additionally, while losses arising from a breach may be covered in part by insurance that we carry, such coverage may not be adequate

for liabilities or losses actually incurred.

may be subject to data privacy and data breach laws in the states in which we do business, and as we expand into other countries, we

may be subject to additional data privacy laws and regulations.

In many states, state data privacy laws (such as the California Consumer

Privacy Act), including application and interpretation, are rapidly evolving.

The rapidly evolving nature of state and federal privacy

laws, including potential inconsistencies between such laws and uncertainty as to their application, adds additional compliance costs

and increases our risk of non-compliance.

While we attempt to comply with such laws, we may not be in compliance at all times in all

Failure to comply with such laws may subject us to fines, administrative actions, and reputational harm.

may delist our securities from its exchange, which could harm our business and limit our stockholders ’ liquidity.

Our common stock is currently

listed on the Nasdaq Global Select Market, which has qualitative and quantitative listing criteria.

However, we cannot assure that our

Class A common stock will continue to be listed on Nasdaq in the future.

In order to continue listing our Class A common stock on Nasdaq,

we must maintain certain financial, distribution and stock price levels.

Generally, we must maintain a minimum amount in stockholders’

equity, a minimum number of holders of our Class A common stock, and a minimum bid price for our Class A common stock.

If we are unable to comply

with the continued listing requirements, our Class A common stock may be subject to delisting.

If Nasdaq delists our Class A common stock

from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities

could be quoted on an over-the-counter market.

If this were to occur, we could face significant material adverse consequences, including:

a limited availability of market quotations for our securities;

reduced liquidity for our securities;

a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;

a limited amount of news and analyst coverage;

a decreased ability to issue additional securities or obtain additional financing in the future.

The National Securities Markets Improvement Act of 1996, which is a

federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered

securities.” If our Class A common stock continues to be listed on Nasdaq, our Class A common stock will be a covered security.

Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate

companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the

sale of covered securities in a particular case.

connection with the issuance of Warrants pursuant to the Amended and Restated Credit Agreement, on January 23, 2024, the Company entered

into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”) with CCP, Blackwell, Coliseum

Capital Co-Invest III, L.P.

(“C-3”), Harvest Master, Harvest Partners, and HSCP (the “Holders”), providing for

the registration under the Securities Act of the Warrants, the shares of Common Stock issuable upon the exercise of the Warrants and the

Class A Common Stock held by the Holders as of such date (the “Registrable Securities”), subject to customary terms and conditions.

The Registration Rights Agreement provides that on or prior to February 22, 2024, the Company was required to prepare and file with the

SEC pursuant to Rule 415 of the Securities Act a registration statement to register the resale of the Registrable Securities.

received an extension from the Holders to file the registration statement on or prior to March 22, 2024.

On March 21, 2024, the Company

filed the registration statement pursuant to the Registration Rights Agreement.

The market price of our Common

Stock could decline as a result of sales in the market by a few large stockholders, such as Coliseum or the Holders, or the perception

that these sales could occur, including as a result of the registration statement filed March 21, 2024.

These sales might also make it

more difficult for us to sell equity securities at a time and price that we deem appropriate.

Our stockholders may experience substantial

dilution in the value of their investment or may otherwise have their interests impaired if we issue additional shares of our capital

stock, including as a result of the exercise of the Warrants.

Our Second Amended and Restated Certificate of Incorporation allows

us to issue up to 300 million shares of our common stock, including 210 million shares of Common Stock and 90 million shares

of Class B Stock, and up to five million shares of undesignated preferred stock.

For example, in February 2023 we issued 13,400,000 shares

of Common Stock pursuant to an underwritten public offering.

To raise additional capital, we may in the future sell additional shares

of our Common Stock or other securities convertible into or exchangeable for our Common Stock at prices that are lower than the prices

paid by existing stockholders, and investors purchasing shares or other securities in the future could have rights superior to existing

stockholders, which could result in substantial dilution to the interests of existing stockholders.

For example, on January 23, 2024,

we issued to the Lenders under the Amended and Restated Credit Agreement Warrants to purchase 20,000,000 shares of our Common Stock (approximately

19% of our currently outstanding Class A Common Stock) at a price of $1.50 per share, subject to certain adjustments.

The Warrants will

expire on the 10-year anniversary of issuance or earlier upon redemption.

The exercise of the Warrants will dilute the value of the Common

Stock and stockholder voting power.

Pursuant to our Certificate

of Incorporation, our board of directors may authorize the issuance of up to five million shares of preferred stock at any time and from

time to time, with such terms and preferences as the board of directors determines and without any stockholder approval other than as

may be required by Nasdaq rules.

The issuance of such shares of preferred stock could dilute the interest of, or impair the voting power

of, our common stockholders.

The issuance of such preferred stock could also be used as a method of discouraging, delaying, or preventing

a change of control.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors